abstract |
Aqueous pharmaceutical solution suitable for injection to a host comprising danofloxacin or a pharmaceutically acceptable salt thereof in an amount of from 60 to 200 mg / ml and magnesium oxide or magnesium chloride or zinc oxide, or zinc acetate mixed with a co-solvent selected from the group consisting of from 2-pyrrolidone, propylene glycol, polyethylene glycol and N-methylpyrrolidone. |